On August 8, 2023, A delegation from Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences.(hereinafter referred to as the "inspection group") visited Anling Biomed (Shenzhen) Co., Ltd. (hereinafter referred to as "Anling Shenzhen"), a wholly-owned subsidiary of ZSHK Laboratories Limited . (hereinafter referred to as "ZSHK"), for inspection and discussion. The CEO of ZSHK, Dr. Li Ming, accompanied the reception with heads of departments, warmly welcomed the inspection team.

The inspection group visited Anling Shenzhen's eight major experimental platforms, including the Pharmacology and Pharmacodynamics Research Center, Safety Pharmacology Research Center, Drugabol Metism Research Center, Safety Evaluation Research Center, Clinical Testing and Pathology Research Center, Macromolecule Bioanalysis Center, Small Molecule Bioanalysis Center, and Surgical Center. They focused on understanding the facilities and functions of each area and highly praised the hardware facilities construction, information support system, and team experience of Anling Shenzhen.

After the tour, the inspection group had a discussion with the department heads of Anling Shenzhen. Dr. Li Ming provided a detailed introduction to the group's scope of business services and project experience. Both sides had in-depth communication on potential collaborations and exchanged ideas and suggestions on cultivating applied high-end talents, aiming to promote the development of the biopharmaceutical industry and strengthen cooperation between Hong Kong and Shenzhen.

The successful completion of this activity will greatly promote the transformation of basic research and innovation in the biopharmaceutical industry in the Greater Bay Area. As a platform for integrated preclinical evaluation services, ZSHK will continue to leverage the advantages of Guangdong, Hong Kong, and Macao connectivity. Anling Shenzhen will also provide professional services to its clients with its well-established experimental platforms and rich project experience.